These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

198 related items for PubMed ID: 15044036

  • 21. Coexistence of three tachykinin receptors coupled to Ca++ signaling pathways in intestinal muscle cells.
    Hellstrom PM, Murthy KS, Grider JR, Makhlouf GM.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):236-43. PubMed ID: 8035320
    [Abstract] [Full Text] [Related]

  • 22. Contribution of tachykinin receptor subtypes to micturition reflex in guinea pigs.
    Yamamoto T, Hanioka N, Maeda Y, Imazumi K, Hamada K, Matsuo M, Manda T, Mutoh S.
    Eur J Pharmacol; 2003 Sep 23; 477(3):253-9. PubMed ID: 14522364
    [Abstract] [Full Text] [Related]

  • 23. Structure-activity relationships of neurokinin A (4-10) at the human tachykinin NK(2) receptor: the role of natural residues and their chirality.
    Warner FJ, Mack P, Comis A, Miller RC, Burcher E.
    Biochem Pharmacol; 2001 Jan 01; 61(1):55-60. PubMed ID: 11137709
    [Abstract] [Full Text] [Related]

  • 24. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
    Meini S, Cucchi P, Bellucci F, Catalani C, Faiella A, Rotondaro L, Quartara L, Giolitti A, Maggi CA.
    Biochem Pharmacol; 2004 Feb 15; 67(4):601-9. PubMed ID: 14757160
    [Abstract] [Full Text] [Related]

  • 25. FK 224, a novel cyclopeptide substance P antagonist with NK1 and NK2 receptor selectivity.
    Morimoto H, Murai M, Maeda Y, Yamaoka M, Nishikawa M, Kiyotoh S, Fujii T.
    J Pharmacol Exp Ther; 1992 Jul 15; 262(1):398-402. PubMed ID: 1378096
    [Abstract] [Full Text] [Related]

  • 26. Isolation and pharmacological characterization of a hamster urinary bladder neurokinin A receptor cDNA.
    Aharony D, Little J, Thomas C, Powell S, Berry D, Graham A.
    Mol Pharmacol; 1994 Jan 15; 45(1):9-19. PubMed ID: 8302285
    [Abstract] [Full Text] [Related]

  • 27. Evidence for the proximity of the extreme N-terminus of the neurokinin-2 (NK2) tachykinin receptor to Cys167 in the putative fourth transmembrane helix.
    Bhogal N, Blaney FE, Ingley PM, Rees J, Findlay JB.
    Biochemistry; 2004 Mar 23; 43(11):3027-38. PubMed ID: 15023054
    [Abstract] [Full Text] [Related]

  • 28. Identification of putative agouti-related protein(87-132)-melanocortin-4 receptor interactions by homology molecular modeling and validation using chimeric peptide ligands.
    Wilczynski A, Wang XS, Joseph CG, Xiang Z, Bauzo RM, Scott JW, Sorensen NB, Shaw AM, Millard WJ, Richards NG, Haskell-Luevano C.
    J Med Chem; 2004 Apr 22; 47(9):2194-207. PubMed ID: 15084118
    [Abstract] [Full Text] [Related]

  • 29. Characterization of ibodutant at NK(2) receptor in human colon.
    Santicioli P, Meini S, Giuliani S, Catalani C, Bechi P, Riccadonna S, Ringressi MN, Maggi CA.
    Eur J Pharmacol; 2013 Feb 28; 702(1-3):32-7. PubMed ID: 23376417
    [Abstract] [Full Text] [Related]

  • 30. Tachykinin NK2 receptors: characterization in the rat small intestine by the use of a peptide agonist and a nonpeptide antagonist as radioligands.
    Renzetti AR, Criscuoli M, Maggi CA.
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul 28; 356(1):139-44. PubMed ID: 9228201
    [Abstract] [Full Text] [Related]

  • 31. Tachykinin-induced contraction of the guinea-pig isolated oesophageal mucosa is mediated by NK(2) receptors.
    Kerr KP, Thai B, Coupar IM.
    Br J Pharmacol; 2000 Dec 28; 131(7):1461-7. PubMed ID: 11090121
    [Abstract] [Full Text] [Related]

  • 32. Isolation and characterization of neurokinin A receptor cDNAs from guinea-pig lung and rabbit pulmonary artery.
    Aharony D, Little J, Thomas C, Powell S, Downey-Jones M, Graham A.
    J Recept Res; 1994 Dec 28; 14(6-8):399-421. PubMed ID: 7877137
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Stepwise modulation of neurokinin-3 and neurokinin-2 receptor affinity and selectivity in quinoline tachykinin receptor antagonists.
    Blaney FE, Raveglia LF, Artico M, Cavagnera S, Dartois C, Farina C, Grugni M, Gagliardi S, Luttmann MA, Martinelli M, Nadler GM, Parini C, Petrillo P, Sarau HM, Scheideler MA, Hay DW, Giardina GA.
    J Med Chem; 2001 May 24; 44(11):1675-89. PubMed ID: 11356103
    [Abstract] [Full Text] [Related]

  • 35. Effect of non-peptide tachykinin NK(1) receptor antagonists on non-adrenergic, non-cholinergic neurogenic mucus secretion in ferret trachea.
    Khawaja AM, Liu Y, Rogers DF.
    Eur J Pharmacol; 1999 Nov 19; 384(2-3):173-81. PubMed ID: 10611439
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Activity of nonpeptide tachykinin antagonists on neurokinin a induced contractions in dog urinary bladder.
    Rizzo CA, Hey JA.
    J Urol; 2000 Jun 19; 163(6):1971-4. PubMed ID: 10799241
    [Abstract] [Full Text] [Related]

  • 40. Characterization of [3H]MEN 11420, a novel glycosylated peptide antagonist radioligand of the tachykinin NK2 receptor.
    Renzetti AR, Catalioto RM, Criscuoli M, Cucchi P, Lippi A, Guelfi M, Quartara L, Maggi CA.
    Biochem Biophys Res Commun; 1998 Jul 09; 248(1):78-82. PubMed ID: 9675089
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.